Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06931626 · ClinicalTrials.gov registry record · Phase 1

Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer

A Phase 1 study of Small-cell Lung Cancer, sponsored by Nerviano Medical Sciences.

Recruiting
Registry status
Phase 1
Development phase
10
Enrollment target
2
Study locations

NCT06931626 is a Phase 1 study of Small-cell Lung Cancer that is actively recruiting participants, run by Nerviano Medical Sciences. The registered enrollment target is 10 participants, below the 232-participant average among 79 other Small-cell Lung Cancer trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06931626, a Phase 1 study of Small-cell Lung Cancer, is actively recruiting participants, sponsored by Nerviano Medical Sciences.

RECRUITING
Registry status
Phase 1
Development phase
10 participants
Enrollment target
2
Study locations

Study Summary

This is an open-label study of NMS-03305293 with Temozolomide (TMZ) in patients with Small Cell Lung Cancer (SCLC). The aim of this study is to determine the safety and tolerability, as well as to evaluate the anti-tumor efficacy and pharmacokinetics of NMS-03305293 in combination with TMZ.

Conditions Studied

Small-cell Lung Cancer

Interventions

  • DRUG Temozolomide
  • DRUG NMS-03305293

Study Locations (2)

Massachusetts

  • Massachusetts General Hospital - Boston

Tennessee

  • Tennessee Oncology, PLLC - Nashville

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2025-08-15
Est. Completion 2027-02-28
Phase Phase 1

Sponsor

Nerviano Medical Sciences

11 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06931626

The ClinicalTrials.gov registry entry for NCT06931626 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 232-participant average among 79 other Small-cell Lung Cancer trials with a reported enrollment target (96% lower). The listed sponsor is Nerviano Medical Sciences, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Small-cell Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Temozolomide is the first listed.

NCT06931626 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Tennessee.

Frequently Asked Questions

What is clinical trial NCT06931626 about?

NCT06931626 is a clinical study titled "Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer". This is an open-label study of NMS-03305293 with Temozolomide (TMZ) in patients with Small Cell Lung Cancer (SCLC). The aim of this study is to determine the safety and tolerability, as well as to evaluate the anti-tumor efficacy and pharmacokinetics of NMS-03305293 in combination with TMZ.

What is the current status of trial NCT06931626?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2025-08-15. Estimated completion is 2027-02-28.

What conditions does trial NCT06931626 study?

This clinical trial studies the following conditions: Small-cell Lung Cancer.

What interventions are being tested in trial NCT06931626?

The interventions under investigation include: Temozolomide (DRUG), NMS-03305293 (DRUG).

Who is sponsoring clinical trial NCT06931626?

This trial is sponsored by Nerviano Medical Sciences, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06931626 being conducted?

This trial has 2 study locations across Massachusetts, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Small-cell Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Small-cell Lung Cancer

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.